Biologics Safety Testing Market 2021 Booming Across the Globe by Product & Service, Application, Test Type, Region and Key Players- Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany)

Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Application (Vaccine, Monoclonal Antibodies, Blood products, Cell & Gene Therapy Products), Test Type (Endotoxin, Myoplasm, Sterility Test) - Global Forecast to 2026

The Biologics Safety Testing Market research report acts as a strong backbone for the industry with which it can outdo the competition. The market is supposed to witness growth during the forecast period due to growing demand at the end-user level. This report comprehensively studies consumption or sales of the market, focuses on the top players with respect to sales, price, revenue, and market share (volume and value) for each region. Analysis of consumer needs by major regions, types, applications in the global market by considering the past, present, and future state of the industry has been conducted. All the market drivers and restraints in the report have been derived using SWOT analysis.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=1132654

The global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination, and rising biopharmaceuticals R&D activities and investments. In addition, emerging markets and increasing biopharmaceutical outsourcing are expected to provide significant growth opportunities for players in the Biologics safety testing market.

The Biologics Safety Testing market is dominated by a few globally established players such

Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and SGS SA (Switzerland), Eurofins Scientific (Luxembourg), Maravai Lifesciences (US), Associates of Cape Cod, Inc. (US), bioMérieux SA (France), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Nelson Laboratories, LLC (US), Bio-Rad Laboratories, Inc. (US) and QIAGEN (Germany),Agilent Technologies, Inc. (US), Pacific BioLabs (US), Microcoat Biotechnologie GmbH (Germany), PromoCell GmbH (Germany), FUJIFILM Wako Pure Chemical Corporation (Japan), and Almac Group (UK).

“By product segment, the service segment accounted for the largest share of the Biologics Safety Testing market”

Based on product and service, the biologics safety testing market is segmented into consumables, services, and instruments. In 2020, the services segment accounted for the largest market share. The large share of this segment can be attributed to the limited finances of biopharmaceutical manufacturers, capacity constraints, need for reduction in the time to market, complex manufacturing requirements, large investments required for establishing manufacturing facilities, and the increasing drugs pipeline, all of which have prompted the shift towards the outsourcing of biologics safety testing to service providers.

”By application, the monoclonal antibodies manufacturingsegment accounted for the largest market share of the Biologics safety testing market “

Based on application, the biologics safety testing market is segmented into monoclonal antibodies manufacturing, vaccines manufacturing, blood and blood products manufacturing, cellular and gene therapy products manufacturing, and other applications. In 2020, the monoclonal antibodies manufacturing segment accounted for the largest market share. The large share of this segment can be attributed to the rising prevalence of diseases and increasing government initiatives for the development of monoclonal antibody drugs.

“Asia Pacific: The fastest-growing region in the Biologics Safety Testing Market”

The Biologics Safety Testing Market in the Asia Pacific region is projected to register the highest growth during the forecast period. Factors such as growing R&D funding, rising product availability, lower outsourcing costs, increasing research activities, increasing applications of oligos in molecular diagnostics & therapeutics, and the rising awareness of oligonucleotides are expected to drive market growth.

“North America accounted for the largest share of the Biologics safety testing market in 2020”

North America accounted for the largest share of the biologics safety testing market in 2020. Rapid growth in the biopharmaceutical industry is the major factor driving the growth of the North American biologics safety testing market. Growing academic and government investments, rising demand for high-quality research tools for data reproducibility, increasing awareness among consumers about product safety, and the presence of major market players in this region are also driving the market for biologics safety testing in North America.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

By Respondent– Supply Side- 80%, Demand Side-20%
By Designation— CXOs- 20%, Executives - 25%, Mangers - 55%
By Region— North America -40%, Europe - 30%, APAC – 20%, LATAM & MEA- 10%

Research Coverage:

The report segments the Biologics Safety Testing market based on region (Asia Pacific, Europe, North America, Latin America and Middle East and Africa), product and service(consumables, services, and instruments), application(monoclonal antibodies manufacturing, vaccines manufacturing, blood and blood products manufacturing, cellular and gene therapy products manufacturing, and other applications.), and test types (endotoxin tests, sterility tests, mycoplasma tests, bioburden tests, virus safety tests, and residual host-cell proteins and DNA detection tests.). The report also provides a comprehensive review of market drivers, opportunities, challenges and trends in the Biologics Safety Testing market.

Inquire for Discount @ https://www.reportsnreports.com/contacts/discount.aspx?name=1132654

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the Biologics Safety Testing market and provides them information on key market drivers, restraints, challenges, and opportunities.

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions Of The Study
1.2.2 Markets Covered
Figure 1 Biologics Safety Testing Market Segmentation
1.2.3 Years Considered For The Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1 Research Approach
Figure 2 Research Design
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 3 Breakdown Of Primaries: Biologics Safety Testing Market
2.1.3 Market Data Estimation And Triangulation
2.1.4 Data Triangulation
Figure 4 Data Triangulation Methodology
2.2 Market Estimation Methodology
Figure 5 Market Size Estimation: Company Revenue Analysis-Based Estimation
Figure 6 Market Size Estimation: Segmental Analysis-Based Estimation
Figure 7 Biologics Safety Testing Market: Final Cagr Projections (2021−2026)
Figure 8 Biologics Safety Testing: Cagr Projections From The Analysis Of Demand-Side Drivers, Opportunities, And Challenges
Figure 9 Biologics Safety Testing Market: Segmental Assessment
2.3 Industry Insights
2.4 Research Assumptions

3 Executive Summary
Figure 10 Biologics Safety Testing Market Share, By Product & Service, 2020
Figure 11 Biologics Safety Testing Market, By Application, 2021 Vs. 2026 (Usd Million)
Figure 12 Biologics Safety Testing Market, By Test Type, 2021 Vs. 2026 (Usd Million)
Figure 13 Geographical Snapshot Of The Biologics Safety Testing Market

4 Premium Insights
4.1 Biologics Safety Testing Market Overview
Figure 14 Growth In The Biologics And Biosimilars Markets To Drive Market Growth
4.2 North America: Biologics Safety Testing Market, By Application And Country (2020)
Figure 15 Monoclonal Antibodies Manufacturing Segment Accounted For The Largest Share Of The North American Market In 2020
4.3 Biologics Safety Testing Market, By Test Type
Figure 16 Residual Host-Cell Proteins & Dna Detection Tests Segment To Register The Highest Cagr During The Forecast Period

5 Market Overview
5.1 Market Dynamics
Figure 17 Biologics Safety Testing Market: Drivers,Opportunities, & Challenges
5.1.1 Drivers
5.1.1.1 Growth In The Biosimilars And Biologics Markets
Figure 18 Total Number Of New Biologics License Application Approvals, Nda Approvals, And Filings (2005–2019)
Table 1 List Of Biological License Application Approvals In The Us, 2019
5.1.1.2 Growing Concerns Over Cell Culture Contamination
5.1.1.3 Rising Biopharmaceuticals R&D Activities And Investments
Figure 19 R&D Spending By Phrma Member Companies,2001–2019 (Usd Billion)
Table 2 Pharmaceutical R&D Spending, By Company, 2019 Vs. 2026 (Usd Billion)
5.1.2 Opportunities
5.1.2.1 Emerging Markets Offer Lucrative Opportunities
5.1.2.2 Increasing Biopharmaceutical Outsourcing
5.1.3 Challenges
5.1.3.1 Dearth Of Skilled Professionals
5.2 Impact Of Covid-19 On The Biologics Safety Testing Market
5.3 Pricing Analysis
Table 3 Average Selling Price Of Biologics Safety Testing Products (2020)
5.4 Value Chain Analysis
Figure 20 Value Chain Analysis Of The Biologics Safety Testing Market
5.5 Ecosystem Analysis Of The Biologics Safety Testing Market
Figure 21 Ecosystem Analysis Of The Biologics Safety Testing Market
5.6 Patent Analysis
Figure 22 Number Of Patents Granted In The Last 20 Years
Table 4 Top 10 Granted Patent Owners (Us) In The Last 20 Years
Figure 23 Top 10 Players With The Highest Number Of Patent Applications
5.7 Regulatory Analysis
5.7.1 Us
5.7.2 Europe
5.8 Porter’s Five Forces Analysis
Table 5 High Capital Investments To Restrict The Entry Of New Players
5.8.1 Threat Of New Entrants
5.8.2 Threat Of Substitutes
5.8.3 Bargaining Power Of Buyers
5.8.4 Bargaining Power Of Suppliers
5.8.5 Intensity Of Competitive Rivalry

Read More.............

Get Direct Order of this Report @ https://www.reportsnreports.com/purchase.aspx?name=1132654

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.